BROMOCRIPTINE IN THE MANAGEMENT OF END OF DOSE DETERIORATION IN PARKINSONS-DISEASE

被引：12
|
作者：
GRIMES, JD
KING, DB
KOFMAN, OS
MOLINANEGRO, P
WILSON, AF
BOUCHARD, S
机构：
[1] NOTRE DAME HOSP, MONTREAL, QUEBEC, CANADA
[2] SANDOZ CANADA, MONTREAL, QUEBEC, CANADA
[3] ROYAL ALEXANDRA HOSP, EDMONTON, ALBERTA, CANADA
[4] VICTORIA GEN HOSP, HALIFAX B3H 2Y9, NS, CANADA
[5] OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ONTARIO, CANADA
[6] MT SINAI HOSP, TORONTO M5G 1X5, ONTARIO, CANADA
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1984年 / 11卷 / 04期
关键词：
D O I：
10.1017/S0317167100045996
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：452 / 456
页数：5
相关论文
共 50 条
  • [21] BROMOCRIPTINE INDUCED IMPOTENCE IN PARKINSONS-DISEASE
    BOWMAN, CE
    BRITISH MEDICAL JOURNAL, 1987, 295 (6599): : 675 - 675
  • [22] BROMOCRIPTINE INDUCED IMPOTENCE IN PARKINSONS-DISEASE
    CLEEVES, L
    FINDLEY, LJ
    BRITISH MEDICAL JOURNAL, 1987, 295 (6594): : 367 - 368
  • [23] BROMOCRIPTINE AND THE CLINICAL SPECTRUM OF PARKINSONS-DISEASE
    RIOPELLE, RJ
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 455 - 459
  • [24] TREATMENT OF PARKINSONS-DISEASE USING BROMOCRIPTINE
    CASTAIGNE, P
    LAPLANE, D
    BOUSSER, MG
    BORIES, F
    NOUVELLE PRESSE MEDICALE, 1977, 6 (17): : 1482 - 1482
  • [25] BROMOCRIPTINE IN THE LONG-TERM MANAGEMENT OF ADVANCED PARKINSONS-DISEASE
    GRIMES, JD
    HASSAN, MN
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1983, 10 (02) : 86 - 90
  • [26] THE CONTROVERSIAL ROLE OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    HARDIE, RJ
    LEES, AJ
    STERN, GM
    CLINICAL NEUROPHARMACOLOGY, 1985, 8 (02) : 150 - 155
  • [27] ADJUNCTIVE THERAPY WITH BROMOCRIPTINE IN PARKINSONS-DISEASE
    TEMLETT, JA
    MING, A
    SALING, M
    FRITZ, VU
    BLUMENFELD, A
    BILCHIK, TR
    BECKER, AL
    FOURIE, PB
    REEF, HE
    SOUTH AFRICAN MEDICAL JOURNAL, 1990, 78 (11): : 680 - 685
  • [28] TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE - REPLY
    LIEBERMAN, AN
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (09): : 508 - 509
  • [29] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
    WODAK, J
    STARK, R
    GILLIGAN, B
    MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
  • [30] SEVERITY OF PARKINSONS-DISEASE AND THE DOSAGE OF BROMOCRIPTINE
    LARSEN, TA
    NEWMAN, R
    LEWITT, P
    CALNE, DB
    NEUROLOGY, 1984, 34 (06) : 795 - 797
12345